SCHEDULE: Vanguard Reports 7.44% Stake in Revvity Inc.
Ownership Filing
Vanguard Capital Management disclosed a beneficial ownership of 8,326,862 shares, representing 7.44% of Revvity Inc.'s common stock as of March 31, 2026.
Summary
- Vanguard Capital Management, along with its affiliates, has reported beneficial ownership of 8,326,862 shares of Revvity Inc. common stock.
- This holding represents 7.44% of the total class of securities.
- The filing indicates sole voting power for 996,882 shares and sole dispositive power for all 8,326,862 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It reports a significant but passive ownership stake by a major institutional investor, which is standard practice and does not inherently signal positive or negative performance for Revvity Inc.
Positives
- Vanguard's significant stake suggests confidence in Revvity's long-term prospects.
- The filing confirms that the shares are held in the ordinary course of business, indicating a passive investment approach rather than an attempt to gain control.
Risks
- While not explicitly stated as a risk in this filing, a large institutional holder like Vanguard could potentially shift its position, impacting share price.
- The filing does not provide details on the specific Vanguard funds or clients holding these shares, which could be relevant for understanding potential selling pressure if those funds face redemptions.
Future Outlook
This filing is a snapshot of ownership as of March 31, 2026, and does not contain forward-looking statements or guidance from Revvity Inc. itself. Vanguard's future outlook for its investment in Revvity is implied by its continued holding.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for large institutional investors like Vanguard, indicating significant holdings in publicly traded companies. This filing confirms Vanguard's substantial investment in the healthcare technology and diagnostics sector, where Revvity operates.
Stakeholder Impact
- Shareholders: The filing confirms a large institutional investor's stake, which can provide a degree of stability to the stock price, but also implies potential for future selling if Vanguard's investment strategy changes.
- Management of Revvity Inc.: The presence of a significant institutional holder like Vanguard may influence corporate governance and strategic decisions.
- Potential Investors: This filing provides transparency on ownership, allowing other investors to assess the shareholder base.
Next Steps
- Vanguard will continue to monitor its investment in Revvity Inc.
- Future filings will be made if Vanguard's ownership stake changes significantly.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of Event Which Requires Filing of this Statement |
| 01/12/1998 | SEC Release No. 34-39538 referenced for reporting securities beneficially owned by Vanguard entities. |
| 04/30/2026 | Date of certification by Ashley Grim, Head of Global Fund Administration. |
Keywords
Revvity Inc, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.